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Background
Since 1997, the Victorian Colorectal Cancer Family
Study (VCCFS) has been studying a large number of
individuals who have had colorectal cancer and their
relatives. When a genetic mutation is identified by the
VCCFS, family members are offered the chance to have
genetic testing through a family cancer clinic to learn of
their result. Between 17% (before August 2003) and 49%
(after August 2003) of individuals offered genetic testing
decline the offer [1], providing a unique opportunity to
conduct research with individuals who decline genetic
testing. Understanding this decision making process is
critical to improving the uptake of genetic testing in
practice [2].
Methods
A sample of participants in the VCCFS who had been
offered genetic testing between 2003 and 2008 were
invited to take part in a qualitative interview about
genetic testing decision-making in the area of colorectal
cancer. The sample included both those who declined
genetic testing (decliners) and those who accepted
genetic testing (acceptors). Thematic analysis was per-
formed to determine the main reason individuals gave
for accepting or declining the offer of genetic testing.
Results
A total of 15 interviews have been conducted, six with
decliners, and nine with acceptors. All participants
recalled the offer of genetic information, and knew of
the hereditary genetic mutation in their family. Each
participant was able to clearly describe their decision.
There were four types of decliners and four types of
acceptors. Individuals declined because 1) Lynch Syn-
drome had been confirmed by other means; 2) fear
about insurance implications; 3) genetic testing
‘wouldn’t change anything’ or 4) a positive result would
cause too much worry. The main reason individuals
accepted the offer of genetic testing was for the sake of
1) their children; 2) their own health; 3) curiosity; or 4)
research. We consider how this decision was related to
both risk perception and screening behaviour.
Conclusions
The key perception informing the genetic testing deci-
sion was the consequence of receiving results. In the
case of decliners, receiving genetic results was perceived
to have either no consequences or negative conse-
quences (financial or emotional). For acceptors, genetic
testing was perceived to have positive consequences
either for their children, themselves, or society. This
research highlights the need to explore risk perceptions,
genetic testing and screening decision making in more
detail in families eligible for genetic testing, in order to
increase the uptake of genetic testing in this group.
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